vax102
Vaccineexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00603811)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vax102
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00921206 | Phase 1 | Jun 1, 2009 | University of Colorado, Denver, VaxInnate Corporation |
| NCT00921947 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2009 | VaxInnate Corporation |
| NCT00921973 | Phase 1 | Jun 1, 2009 | VaxInnate Corporation |
| NCT00603811 | Phase 1 | Sep 1, 2007 | Bill and Melinda Gates Foundation, University of Texas, Galveston, VaxInnate Corporation |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| VaxInnate Corporation | For profit | 4 | 4 | 2 | 2007 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of Colorado, Denver | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Texas, Galveston | Academic/Hospital | 1 | 0 | 1 | 2007 |
4 organizations
Page 1 / 1